Michelle Donelan
Main Page: Michelle Donelan (Conservative - Chippenham)Department Debates - View all Michelle Donelan's debates with the Department for Education
(3 years, 7 months ago)
Commons ChamberAlthough the Department of Health and Social Care leads on this area, I would like to take this opportunity to commend the University of Central Lancashire for the excellent job it is doing. The Government are committed to supporting the NHS by ensuring that its future workforce needs are met. Over recent years we have created an extra 1,500 medical school places and opened five new medical schools across the country, and as a result we have seen record numbers of medical students in training.
Mr Speaker, as a neighbouring MP to me, you know that the quality of education at the University of Central Lancashire medical school has been independently assessed as excellent. At a time when the health service has been crying out for more doctors during the covid-19 pandemic, can the Minister please provide assurances that, through her discussions with the Department for Health and Social Care, the University of Central Lancashire will be allocated an evidence-based significant increase in its permanent allocation of domestic medical school places, for the benefit of the county of Lancashire and the wider north-west region as a whole?
I am sure that Chorley would like to hear the answer.
The cap on medical places was lifted last year, and those medical students who had to defer will not count towards the cap this year. If medical training places are to be permanently raised, there will be a process for medical schools to apply for a proportion of the expansion, just as was the case with the recent uplift of 1,500. I am sure that the hon. Member will be more than happy to meet the Minister for Care, my hon. Friend the Member for Faversham and Mid Kent (Helen Whately), who also looks after workforce matters, and that she would be only too happy to discuss the issue with him.
My Department and I regularly discuss research in universities in England with the Department for Business, Energy and Industrial Strategy and with the Minister for science, research and innovation, my hon. Friend the Member for Derby North (Amanda Solloway). Overall, Government investment in research and development across the UK is up to £14.9 billion in 2021-22, following four preceding years of significant growth. This shows the clear benefits of the Union in delivering on science and research across the nation.
The Universities of Glasgow, Leeds, Liverpool, Newcastle and Coventry have all been leaders in the global challenges research fund. With the cuts to ODA, they are now having to find additional seven-figure funding to keep life-saving research going. Is this really the Tories’ fabled levelling-up agenda?
The Government recognise the importance of supporting international research partnerships and the UK research sector, especially our universities. Our commitment to research and innovation was clearly demonstrated by the recent Budget announcement that we are increasing investment in research and development to £14.6 billion. International collaboration is central to a healthy and productive R&D sector and, as a result of the policies of this Government, UK scientists will have access to more public funding than ever before.
Twelve flagship research hubs were supposed to run projects lasting five to 10 years in support of the sustainable development goals. Some of those projects are midway through clinical trials on humans but, thanks to the recent cuts, might not be able to continue, thereby jeopardising both the research and research jobs. How on earth can the Government justify funding cuts to research projects in the middle of human clinical trials, in clear violation of medical ethics?
The hon. Gentleman might like to take up his question with the Department for Business, Energy and Industrial Strategy, which is ultimately responsible for research. On 1 April, BEIS set out an additional £250 million of funding for R&D—as a result of which, as I have said, UK scientists will have access to more public funding than ever before—taking the total Government investment in R&D to £14.9 billion in 2021-22, despite what the Opposition would have the public believe.
Because of the ODA cuts, universities have reported that research contracts have been terminated, sometimes with just a few hours’ notice. This has undermined trust between researchers, universities and UK Research and Innovation, and it also means that research commissioners now require a risk assessment on the UK Government’s ability to honour contracts. Why does the Minister think it is acceptable that the UK Government’s promises mean so little that they need to be risk assessed?
On the actual ODA allocations, BEIS is currently working with UKRI, all global challenge research funds and its Newton fund delivery partners to manage the financial year 2021-22, including by determining which projects will go ahead. Its delivery partners have been communicated with, and award holders will set out the next stages of the review of ODA funding next year and explore the options available for individual programmes.
I have been working closely with my counterparts across Government, including in the Department of Health and Social Care, about how covid-19 policies affect international and domestic students. Immigration concessions allow for the ongoing provision of online learning this academic year, meaning that international students can study remotely from the UK or in their home country. Universities have informed us that a sizeable number have stayed in the UK throughout.
International students are hugely important to our universities. With India added to the red list, there is real concern that the cost of hotel quarantine will be a deal breaker for some. Can the Minister tell us whether universities will be allowed to manage the quarantine system for themselves, which they are well qualified to do, and how soon could that be resolved? If not, who or what is the obstacle?
International students, including those from India, are indeed a vital and valued part of our higher education sector and communities. The UK was one of the first countries to introduce important visa concessions for international students at the very start of the pandemic. That has been flexible throughout, including extending the deadline for eligibility for the graduate route to 21 June. We continue to work with the Department of Health and Social Care to ensure that the UK remains as accessible and welcoming as possible. International students are also eligible for the additional £85 million that we have given universities for support with hardship.